Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy
Cancer Medicine · 2024
DOI: 10.1002/cam4.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Zhihui Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Magnetic Resonance Imaging, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science International Cooperation Project, Science and Technology Commission of Shanghai Municipality, Foundation of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Objectives
To determine the imaging details and diagnostic information of the treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal adenocarcinoma at 9.4T magnetic resonance imaging (MRI) by ex vivo.
Methods
Fifteen cases with locally advanced rectal cancer (LARC) followed by radical surgery after nCRT between September 2022 and February 2023 were recruited. Resected specimens were fixed in a perfluoropolyether‐filled test tube and scanned with a 3.0T and 9.4T MRI system ex vivo. The residual tumor depth and MRI‐based tumor regression grade (TRG) were subjectively assessed and then compared with the pathological findings.
Results
The ex vivo 9.4T T2WI without fat suppression clearly differentiated tumor tissue, fibrosis and normal rectal wall, which clearly corresponded to the pathologic tissues of the rectal specimens. The TRG could be accurately assessed on ex vivo 9.4T images in 13/15 specimens (86.7%), while in 11/15 specimens (73.3%) on ex vivo 3.0T images.
Conclusion
Ex vivo 9.4T MR imaging clearly displayed the components of rectal wall and proved excellent diagnostic performance for evaluating the treatment response to nCRT, which allow radiologists to understand and then assess more accurately the TRG of LARC after nCRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Radiology, Changhai Hospital, The Navy Medical University, Shanghai, China.
- Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Clinical Neuroscience Center, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- United Imaging Healthcare, Shanghai, China.
ORCID-Profile: Jianping Lu, Fu Shen
Förderung
- Shanghai Science International Cooperation Project
- Science and Technology Commission of Shanghai Municipality
- Foundation of Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Changhai Hospital of Shanghai
- young medical talents funding project of Shanghai
Zitieren
APA
Li, Z., Yuan, Y., Liu, M., Bo, T., Ma, X., Wang, H., Chen, C., Shi, X., Wang, H., Bai, C., Ni, X., Shao, C., Lu, Y., Lu, J., & Shen, F. (2024). Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.70075
Vancouver
Li Z, Yuan Y, Liu M, Bo T, Ma X, Wang H, et al. Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy. Cancer Medicine. 2024. doi:10.1002/cam4.70075
BibTeX
@article{Li2024,
author = {Li, Zhihui and Yuan, Yuan and Liu, Minglu and Bo, Tingting and Ma, Xiaolu and Wang, Hanqi and Chen, Chen and Shi, Xiaohui and Wang, Hao and Bai, Chenguang and Ni, Xiang and Shao, Chengwei and Lu, Yong and Lu, Jianping and Shen, Fu},
title = {Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70075}
}
EUVIMED